Please login to the form below

Not currently logged in
Email:
Password:

ABPI appoints value and access manager

Christine Rowland joins from Pfizer
ABPI_Christine-Rowland

Christine Rowland has been appointed to the newly created position of value and access manager at the Association of the British Pharmaceutical Industry (ABPI).

Rowland will work on a range of projects to improve patient access to innovative medicines, in line with the ABPI's strategic objectives around health technology assessment and market access.

Rowland joins the ABPI from Pfizer where she spent 12 years in a range of roles, including sales, marketing, and market access, covering areas such as oncology and rare diseases. In addition to 17 years in the pharmaceutical industry, Rowland spent a decade with the NHS as a nurse and midwife.

“I am delighted to join the ABPI at this time of great change in the landscape of the UK health system and the NHS,” Rowland said.

The new role will see her join the ABPI's 23-strong commercial department. ABPI director of value and access Paul Catchpole said Rowland was a very welcome addition to the team at a time when the APPI is leading an increasing number of commercial initiatives.

“These include the implementation of the new PPRS scheme, working with NICE on value based assessment and helping our members with the changing NHS landscape whilst continuing to push for greater use of newer medicines,” added Catchpole.

15th May 2014

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...